Originally published Monday, October 6, 2008 at 12:00 AM
Comments (0)
E-mail article
Print view
Dendreon shares leap on mixed news for Provenge
Dendreon's interim results from a trial of its prostate-cancer drug Provenge show mixed results, but stock soars anyhow.
Seattle Times business reporter
Dendreon said Monday that Provenge demonstrably improved survival among prostate cancer patients, according to long-awaited interim results from a clinical trial.
The results sent Dendreon shares soaring, but were not strong enough for the company to ask federal regulators for speedier approval. Instead, the Seattle biotech firm will await the final analysis, scheduled for mid-2009.
The news is "not as good as it could have been, nor as bad as it could have been," said Paul Latta, an analyst with McAdams Wright Ragen.
Dendreon shares traded at $6.93, up 33 percent, after jumping as high as $9 in early morning trading, against the dismal backdrop painted by a global financial shakeout.
Provenge, Dendreon's lead therapy, which would be the first commercial immunetherapy to fight cancer, if it is approved.
But it has been a roller-coaster ride for many investors. In early 2007 the company stock rode as high as $19 on hopes that the U.S. Food and Drug Administration would approve the product in May of that year.
But the agency decided to withhold approval, asking for more data instead. That triggered a sharp fall in the stock price and an angry response from prostate cancer patients eager for a promising treatment.
Hopes soared again when the FDA said it would look at the interim data presented today as sufficient to support an application for approval. But the data "did not meet the pre-specified criteria" for Dendreon to modify the marketing approval it has pending at the FDA, said Chief Executive Mitch Gold in a conference call.
In order to meet its goals, Dendreon needs to demonstrate a 22 percent reduction in the risk of death among patients using Provenge, based on 304 patients, the company said.
The final analysis of the data was originally due in 2010, but the last March company redesigned the clinical trial in order to fast-forwards the results by a year.
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Copyright © 2008 The Seattle Times Company
More Business & Technology headlines...
E-mail article
Print view Share:
Digg
Newsvine
![]()
The local, public face of Chase, Phyllis Campbell is trading on trust
10 investing missteps to avoid
Sunday Buzz: Boeing fighter to run on biofuel; Mastro bankruptcy trustee keeps job
On the Economy: Washington state has to play the add-value card, not low-cost-leader ace

Mourners gather at KeyArena for slain officer's memorial
Mourners gathered at KeyArena for the memorial service of Seattle police Officer Timothy Brenton on November 6, 2009.
nwjobs

Post a comment

Michelle Goodman blogs about work/life balance.
How to tell your office you're gravely ill
Post a comment
nwautos

Choosing a new sedan? Weigh the impact of your choice on your wallet and on the planet.
Post a comment
- Flags were key link to cop slaying, bombings
- Suspect shot as city mourns slain officer
- Bombs, guns found at home of suspect in Officer Brenton's slaying
- Briefs | Soccer: New Mexico suspends hair-pulling player Elizabeth Lambert
- How an underdog named Mike McGinn took City Hall
- Huskies suffer another heartbreaking loss to UCLA
- 3 Cascade Mountain passes close due to snow; more rain, wind expected Sunday
- McGinn pulling away as late ballots come in
- Using anti-shooter tactics, civilian Army police officer brought down gunman
- The birth of 'Grunge,' in photos by Michael Lavine
- U.S. House passes health plan
356 - Weapons, bomb-making materials found in suspect's apartment
337 - Bombs, guns found at home of suspect in Officer Brenton's slaying
246 - Decision day for health care in the House
210 - Grading the game
158 - Referendum 71 show's Washington's strategy for marriage equality is working
157 - How an underdog named Mike McGinn took City Hall
80 - Sounders FC-Dynamo playoff Game 2 thread
79 - Game thread: Detroit Lions at Seattle Seahawks, Nov. 8
74 - Fort Hood shooting suspect had shown troubling signs
66
- Suspect shot as city mourns slain officer
- Flags were key link to cop slaying, bombings
- The birth of 'Grunge,' in photos by Michael Lavine
- 10 investing missteps to avoid
- Bombs, guns found at home of suspect in Officer Brenton's slaying
- How an underdog named Mike McGinn took City Hall
- How do innovators think?
- 10 ways to take control of your health
- Tlingit heritage helps glass artist Preston Singletary break new ground
- Danny Westneat | Lee the Horse Logger found slow wagon shrank tumor





